{
  "id": "mhgap#risk_safety_3bdf9d3f",
  "content": "with fosphenytoin. Both levetiracetam and sodium\nneed to be infused over 20 minutes. Time is of the\nvalproate are broad spectrum medicines active\nessence while treating status epilepticus.\n12 Sharma S, Jain P, Aneja S. Antiseizure medicine treatment for established status epilepticus in adults. 2023 (in preparation).\n76\n3. Recommendations\nagainst all types of seizures, and hence may be a Research gaps\ngood agent for maintenance therapy after the acute y Most of the evidence is from HICs. Further research is\ncontrol of seizures in adults with genetic generalized needed in LMICs.\nepilepsy or when the type of seizure/epilepsy\ny The studies had a small number of older adults. This\nsyndrome is not clear.\nis a special population group with several comorbid\ny There is low- to moderate-quality evidence that conditions and pharmacokinetics of medicines may\nthe safety profile of levetiracetam was better than be different in this age group.\nfosphenytoin, in terms of lesser cardiovascular\ny Post-trauma seizures may require special\nadverse events.\nconsideration – generally not included in studies.\ny Sodium valproate has been associated with hepatic\ny There is limited information on the proportion of\nside-effects, in terms of raised transaminases and",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "risk_safety",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Risk Safety with fosphenytoin. Both levetiracetam and sodium\nneed to be infused over 20 minutes. Time is of the\nvalproate are broad spectrum medicines active\nessence while treating status epilepticus.\n12 Sharma S, Jain P, Aneja S. Antiseizure medicine treatment for established status epilepticus in adults. 2023 (in preparation).\n76\n3. Recommendations\nagainst all types of seizures, and hence may be a Research gaps\ngood agent for maintenance therapy after the acute y Most of the evidence is from HICs. Further research is\ncontrol of seizures in adults with genetic generalized needed in LMICs.\nepilepsy or when the type of seizure/epilepsy\ny The studies had a small number of older adults. This\nsyndrome is not clear.\nis a special population group with several comorbid\ny There is low- to moderate-quality evidence that conditions and pharmacokinetics of medicines may\nthe safety profile of levetiracetam was better than be different in this age group.\nfosphenytoin, in terms of lesser cardiovascular\ny Post-trauma seizures may require special\nadverse events.\nconsideration – generally not included in studies.\ny Sodium valproate has been associated with hepatic\ny There is limited information on the proportion of\nside-effects, in terms of raised transaminases and With fosphenytoin. both levetiracetam and sodium\nneed to be infused over 20 minutes."
}